B cells and autoimmune liver diseases

Autoimmunity Reviews

Volumn 5, Issue 7, 2006, Pages 449-457

  Moritoki, Yuki ^a,b   Lian, Zhe Xiong ^a   Ohsugi, Yoshiyuki ^c   Ueno, Yoshiyuki ^b   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Chugai Pharmaceutical Co L   (Japan)

Author keywords

Autoantibodies; Autoimmune hepatitis; Autoimmunity; B cells; Primary biliary cirrhosis; Primary sclerosing cholangitis; Toll like receptors

Indexed keywords

AUTOANTIBODY; CYTOKINE; GAMMA INTERFERON; TOLL LIKE RECEPTOR;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BACTERIAL INFECTION; CLINICAL FEATURE; CYTOKINE PRODUCTION; DNA POLYMORPHISM; HUMAN; HUMORAL IMMUNITY; IMMUNOGENETICS; LIVER DISEASE; LIVER TRANSPLANTATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; REGULATORY T LYMPHOCYTE; REVIEW; SEROLOGY; T LYMPHOCYTE ACTIVATION; TRANSCYTOSIS;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; HUMANS; LIVER DISEASES;

EID: 33747242809     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.02.006     Document Type: Review

References (40)

1. Zauli D., Ghetti S., Grassi A., Descovich C., Cassani F., Ballardini G., et al. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology 25 (1997) 1105-1107
2. Bachrich T., Thalhammer T., Jager W., Haslmayer P., Alihodzic B., Bakos S., et al. Characterization of autoantibodies against uridine-diphosphate glucuronosyltransferase in patients with inflammatory liver diseases. Hepatology 33 (2001) 1053-1059
3. Muratori L., Sztul E., Muratori P., Gao Y., Ripalti A., Ponti C., et al. Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1. Hepatology 34 (2001) 494-501
4. Wies I., Brunner S., Henninger J., Herkel J., Kanzler S., Meyer zum Buschenfelde K.H., et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 355 (2000) 1510-1515
5. Yamauchi K., Yamaguchi N., Furukawa T., Takatsu K., Nakanishi T., Ishida K., et al. A murine model of acute liver injury induced by human monoclonal autoantibody. Hepatology 42 (2005) 149-155
6. Czaja A.J., and Donaldson P.T. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev 174 (2000) 250-259
7. Vergani D., and Mieli-Vergani G. Autoimmune hepatitis. Autoimmun Rev 2 (2003) 241-247
8. Djilali-Saiah I., Ouellette P., Caillat-Zucman S., Debray D., Kohn J.I., and Alvarez F. CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis. Hum Immunol 62 (2001) 1356-1362
9. Teft W.A., Kirchhof M.G., and Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol 24 (2006) 3.1-3.33
10. Longhi M.S., Ma Y., Bogdanos D.P., Cheeseman P., Mieli-Vergani G., and Vergani D. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 41 (2004) 31-37
11. Kaplan M.M., and Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 353 (2005) 1261-1273
12. Van de Water J., Gershwin M.E., Leung P., Ansari A., and Coppel R.L. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med 167 (1988) 1791-1799
13. Surh C.D., Coppel R., and Gershwin M.E. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope. J Immunol 144 (1990) 3367-3374
14. Ishibashi H., Shimoda S., and Gershwin M.E. The immune response to mitochondrial autoantigens. Semin Liver Dis 25 (2005) 337-346
15. Van de Water J., Ansari A.A., Surh C.D., Coppel R., Roche T., Bonkovsky H., et al. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol 146 (1991) 89-94
16. Shimoda S., Nakamura M., Ishibashi H., Hayashida K., and Niho Y. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 181 (1995) 1835-1845
17. Odin J.A., Huebert R.C., Casciola-Rosen L., LaRusso N.F., and Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 108 (2001) 223-232
18. Fukushima N., Nalbandian G., Van De Water J., White K., Ansari A.A., Leung P., et al. Characterization of recombinant monoclonal IgA anti-PDC-E2 autoantibodies derived from patients with PBC. Hepatology 36 (2002) 1383-1392
19. Matsumura S., Van De Water J., Leung P., Odin J.A., Yamamoto K., Gores G.J., et al. Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology 39 (2004) 1415-1422
20. Pasare C., and Medzhitov R. Control of B-cell responses by toll-like receptors. Nature 438 (2005) 364-368
21. Kikuchi K., Lian Z.X., Yang G.X., Ansari A.A., Ikehara S., Kaplan M., et al. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 128 (2005) 304-312
22. Selmi C., Invernizzi P., Zuin M., Podda M., and Gershwin M.E. Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology. Semin Liver Dis 25 (2005) 265-280
23. Martinez O.M., Villanueva J.C., Gershwin M.E., and Krams S.M. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 21 (1995) 113-119
24. Aoki C.A., Bowlus C.L., and Gershwin M.E. The immunobiology of primary sclerosing cholangitis. Autoimmun Rev 4 (2005) 137-143
25. Terjung B., and Worman H.J. Anti-neutrophil antibodies in primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 15 (2001) 629-642
26. Lian Z.X., Okada T., He X.S., Kita H., Liu Y.J., Ansari A.A., et al. Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations. J Immunol 170 (2003) 2323-2330
27. Perrier P., Martinez F.O., Locati M., Bianchi G., Nebuloni M., Vago G., et al. Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: induction of the B cell-activating chemokine, CXC chemokine ligand 13. J Immunol 172 (2004) 7031-7042
28. Wen L., Shinton S.A., Hardy R.R., and Hayakawa K. Association of B-1 B cells with follicular dendritic cells in spleen. J Immunol 174 (2005) 6918-6926
29. Tsuneyama K., Harada K., Yasoshima M., Kaji K., Gershwin M.E., and Nakanuma Y. Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study. J Pathol 186 (1998) 126-130
30. Harada K., Ohba K., Ozaki S., Isse K., Hirayama T., Wada A., et al. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree. Hepatology 40 (2004) 925-932
31. Novobrantseva T.I., Majeau G.R., Amatucci A., Kogan S., Brenner I., Casola S., et al. Attenuated liver fibrosis in the absence of B cells. J Clin Invest 115 (2005) 3072-3082
32. Bourke E., Bosisio D., Golay J., Polentarutti N., and Mantovani A. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 102 (2003) 956-963
33. Applequist S.E., Wallin R.P., and Ljunggren H.G. Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol 14 (2002) 1065-1074
34. Liu S., Gallo D.J., Green A.M., Williams D.L., Gong X., Shapiro R.A., et al. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun 70 (2002) 3433-3442
35. Wang A.P., Migita K., Ito M., Takii Y., Daikoku M., Yokoyama T., et al. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis. J Autoimmun 25 (2005) 85-91
36. Matsumura T., Ito A., Takii T., Hayashi H., and Onozaki K. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res 20 (2000) 915-921
37. Sanchez-Campillo M., Chicano A., Torio A., Martin-Orozco E., Gamiz P., Hernandez-Caselles T., et al. Implication of CpG-ODN and reactive oxygen species in the inhibition of intracellular growth of Salmonella typhimurium in hepatocytes. Microbes Infect 6 (2004) 813-820
38. Harada K., Ohira S., Isse K., Ozaki S., Zen Y., Sato Y., et al. Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related molecules in cultured biliary epithelial cells. Lab Invest 83 (2003) 1657-1667
39. Mueller T., Kobayashi N., Shibolet O., and Podolsky D. TH1 cytokines promote toll-like receptor signaling in human biliary epithelial cells. Hepatology 42 (2005) 202A
40. Kita H., Mackay I.R., Van De Water J., and Gershwin M.E. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 120 (2001) 1485-1501